The Valley Desk

Clinical trial reportBlood advancesPublished

Infections and parameters of humoral immunity with talquetamab in relapsed/refractory multiple myeloma in MonumenTAL-1

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Clinical trial report
Venue
Blood advances
Published
Subject terms
Humans; Multiple Myeloma; Antibodies, Bispecific; Adult; Aged; Middle Aged; Female; Male; Immunity, Humoral; Infections
PubMed ID
40864183
PubMed Central ID
PMC12661299
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal